Back to UBS Group AG UBS Group AG

ALDXALDX
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in ALDEYRA THERAPEUTICS INC

UBS Group AG holds 301,940 shares of ALDX (ALDEYRA THERAPEUTICS INC), worth $643,132 as of 2026-Q2. The position was decreased (-43.8% shares). ALDX represents 0.0% of UBS Group AG's portfolio.

Current Value

$643,132

Current Shares

301,940

Total Value Change

+$500,141

Total Shares Change

+275,411

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
301,940
-43.8%
$643,1320.0%$2.13
0
2026-Q1
Increased
537,569
+461.9%
$908,4920.0%$5.11
40
2025-Q4
Decreased
95,677
-52.3%
$495,6070.0%$5.15
0
2025-Q3
Increased
200,739
+87.2%
$1M0.0%$5.21
39
2025-Q2
Increased
107,253
+13.5%
$410,7790.0%$3.79
27
2025-Q1
Increased
94,470
+0.2%
$543,2030.0%$6.67
24
2024-Q4
Increased
94,275
+255.4%
$470,4320.0%$5.02
39
2024-Q3
Decreased
26,529
-44.8%
$142,9910.0%$5.50
0

Other major holders of ALDX: BNP PARIBAS FINANCIAL MARKETS, Verition Fund Management LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used